ImageneBio (IMA) Tax Rate (2024 - 2025)
ImageneBio's (IMA) quarterly Tax Rate came in at 0.4% in Q3 2025, up 303.46% quarter-over-quarter from 0.2% in Q2 2025.
Powered by 
Analysis
ImageneBio (IMA) Tax Rate (2024 - 2025) Analysis & Trends
ImageneBio has disclosed Tax Rate across 2 years of filings, most recently posting 0.4% for Q3 2025.
- In Q3 2025, Tax Rate changed N/A year-over-year to 0.4%; the TTM figure through Sep 2025 stood at 0.17% (changed N/A YoY), while the FY2024 annual figure was 0.31%, down 55.0% from the prior year.
- Tax Rate came in at 0.4% for Q3 2025 at ImageneBio, up from 0.2% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.4% in Q3 2025 to a low of 0.88% in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 0.40% |
| Jun 30, 2025 | -0.20% |
| Mar 31, 2025 | -0.46% |
| Dec 31, 2024 | -0.88% |
| Jun 30, 2024 | -0.45% |
| Mar 31, 2024 | -0.17% |